Explore FHI 360

Published research

How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?

Published research

HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention

Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): Briefs

The EpiC project offers knowledge and tools to strengthen HIV programming.

Published research

HIV-related intersectional stigma and discrimination measurement: State of the science

Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): COVID-19 and HIV Technical Resources

The EpiC project produces technical resources on mitigating the impact of the COVID-19 pandemic on HIV programming worldwide.

Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): Trainings, Tools and Guides

The EpiC project offers knowledge and tools to strengthen HIV programming.

Video

SIDHAS Success Stories: Operation Triple Zero Initiative

Learn about Operation Triple Zero, an initiative of FHI 360's SIDHAS project, which supports adolescents living with HIV.

Publication

OPTIONS - A Value Proposition for Investment in a Central Platform for PrEP Introduction and Scale-up

The OPTIONS Consortium describes how their work catalyzed the rollout of antiretroviral-based HIV prevention products known as pre-exposure prophylaxis, or PrEP.

Feature

HIV survey in Nigeria yields data to improve HIV programming

In Nigeria, the Akwa Ibom AIDS Indicator Survey (AKAIS) generated more accurate data than previously available. The data will be used to improve Akwa Ibom State’s response to HIV.

Published research

Attitudes and perceptions toward novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey

The authors conducted a survey of stakeholders with experience and expertise in microbicide and HIV prevention clinical trials. They found that methods that require no additional input from the participant and no modifications to the existing ring product are viewed as more acceptable to trial participants and more feasible to implement in the field.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?

HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention

Meeting Targets and Maintaining Epidemic Control (EpiC): Briefs

HIV-related intersectional stigma and discrimination measurement: State of the science

Meeting Targets and Maintaining Epidemic Control (EpiC): COVID-19 and HIV Technical Resources

Meeting Targets and Maintaining Epidemic Control (EpiC): Trainings, Tools and Guides

SIDHAS Success Stories: Operation Triple Zero Initiative

OPTIONS - A Value Proposition for Investment in a Central Platform for PrEP Introduction and Scale-up

HIV survey in Nigeria yields data to improve HIV programming

Attitudes and perceptions toward novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

23 Results Found

Attitudes and perceptions toward novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey